G 50 (Topiramate 50 mg)
Pill with imprint G 50 is Yellow, Round and has been identified as Topiramate 50 mg. It is supplied by Glenmark Generics Inc..
Topiramate is used in the treatment of epilepsy; lennox-gastaut syndrome; seizure prevention; migraine prevention; seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for G 50
Topiramate
- Imprint
- G 50
- Strength
- 50 mg
- Color
- Yellow
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Glenmark Generics Inc.
- Inactive Ingredients
-
lactose monohydrate,
microcrystalline cellulose,
magnesium stearate,
titanium dioxide,
polysorbate 80,
water,
ferric oxide yellow,
FD&C Yellow No. 6,
sodium starch glycolate type A potato,
corn starch
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 68462-0153 | Glenmark Pharmaceuticals Inc. |
| 35356-0470 | Lake Erie Medical and Surgical Supply (repackager) |
| 54569-6138 | A-S Medication Solutions, LLC (repackager) |
Related Images for "G 50"
More about topiramate
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 1112 Reviews
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- FDA Alerts (3)
Consumer resources
- Topiramate
- Topiramate (Advanced Reading)
- Topiramate Extended-Release Capsules
- Topiramate Extended-Release Sprinkle Capsules
- Topiramate Tablets
- Topiramate Sprinkle Capsules
Other brands: Topamax, Trokendi XR, Topamax Sprinkle, Qudexy XR, Topiragen
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
